Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03677141
Title A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | AUT

Facility Status City State Zip Country Details
University of Alabama Birmingham Birmingham Alabama 35233 United States Details
University of California; Moores Cancer Center La Jolla California 92093 United States Details
University of California, Los Angeles (UCLA) - Hematology/Oncology Santa Monica Santa Monica California 90404-2023 United States Details
Banner MD Anderson Cancer Center Greeley Colorado 85234 United States Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
University of Miami Miller School of Medicine Miami Florida 33136 United States Details
University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109-0934 United States Details
Mayo Clinic Cancer Center Rochester Minnesota 55905 United States Details
Rhode Island Hospital Providence Rhode Island 02903-4801 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
Scott and White Hospital; Cancer Center Temple Texas 76508 United States Details
Medical College of Wisconsin, Inc. Milwaukee Wisconsin 53226-3596 United States Details
Uniklinikum Salzburg, LKH; Univ.Klinik f. Innere Medizin III der PMU Salzburg 5020 Austria Details
LKH Steyr Steyr 4400 Austria Details
Medizinische Universität Wien, Allgemeines Krankenhaus der Stadt Wien Wien 1090 Austria Details
Hanusch-Krankenhaus Wien 1140 Austria Details
CHU Henri Mondor; Service d'Oncologie Medicale Creteil 94010 France Details
Centre Leon Berard Lyon 69008 France Details
Hôpital Saint-Louis Paris 75475 France Details
Centre Henri Becquerel- Centre de Lutte Contre le Cancer Saint Herblain 44805 France Details
Gustave Roussy Villejuif 94805 France Details
Pusan National University Yangsan Hospital Gyeongsangnam-do 50612 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
Samsung Medical Center Seoul 135-710 Korea, Republic of Details
Maria Sklodowska-Curie Memorial Cancer Centre Gliwice 44-102 Poland Details
Ma?opolskie Centrum Medyczne Kraków 30-501 Poland Details
Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka Slupsk 76-200 Poland Details
Instytut Hematologii i Transfuzjologii; Klinika Zaburze? Hemostazy i Chorób Wewn?trznych Warsaw 02-776 Poland Details
Katedra i Klinika Hematologii; Nowotworów Krwi i Transplantacji Szpiku Wroc?aw Poland Details
Institut Catala d?Oncologia Hospital Germans Trias i Pujol Badalona Barcelona 08916 Spain Details
Clinica Universidad de Navarra Pamplona Navarra 31008 Spain Details
Hospital Universitario Virgen Macarena Seville Sevilla 41071 Spain Details
Hospital de la Santa Creu i Sant Pau Barcelona 08025 Spain Details
Hospital San Pedro de Alcantara; Servicio de Hematología Caceres 10003 Spain Details
Hospital General Universitario Gregorio Marañon Madrid 28007 Spain Details
Hospital Universitario La Paz Madrid 280146 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from for the field